Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frida G Ceja

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Antimicrobial Agents and Chemotherapy|September 20, 2017
Changing Antimalarial Drug Sensitivities in UgandaStephanie A Rasmussen, Frida G Ceja, Melissa D Conrad, et al.
Nature Communications|October 26, 2022
Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern UgandaPatrick K Tumwebaze, Melissa D Conrad, Martin Okitwi, et al.
The Lancet. Microbe|September 23, 2021
Drug susceptibility of <i>Plasmodium falciparum</i> in eastern Uganda: a longitudinal phenotypic and genotypic studyPatrick K Tumwebaze, Thomas Katairo, Martin Okitwi, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2024
The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh <i>Plasmodium falciparum</i> isolatesMartin Okitwi, Douglas A Shoue, Lisa A Checkley, et al.
Journal of Medicinal Chemistry|May 12, 2020
Lead Optimization of Second-Generation Acridones as Broad-Spectrum AntimalarialsPapireddy Kancharla, Rozalia A Dodean, Yuexin Li, et al.
ACS Infectious Diseases|November 11, 2024
Tambjamines as Fast-Acting Multistage AntimalarialsAmrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|September 20, 2017
Changing Antimalarial Drug Sensitivities in UgandaStephanie A Rasmussen, Frida G Ceja, Melissa D Conrad, et al.
Nature Communications|October 26, 2022
Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern UgandaPatrick K Tumwebaze, Melissa D Conrad, Martin Okitwi, et al.
The Lancet. Microbe|September 23, 2021
Drug susceptibility of <i>Plasmodium falciparum</i> in eastern Uganda: a longitudinal phenotypic and genotypic studyPatrick K Tumwebaze, Thomas Katairo, Martin Okitwi, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2024
The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh <i>Plasmodium falciparum</i> isolatesMartin Okitwi, Douglas A Shoue, Lisa A Checkley, et al.
Journal of Medicinal Chemistry|May 12, 2020
Lead Optimization of Second-Generation Acridones as Broad-Spectrum AntimalarialsPapireddy Kancharla, Rozalia A Dodean, Yuexin Li, et al.
ACS Infectious Diseases|November 11, 2024
Tambjamines as Fast-Acting Multistage AntimalarialsAmrendra Kumar, Yuexin Li, Rozalia A Dodean, et al.
Pageof 1